With the acquisition of Burt's Bees, Clorox could experience significant growth in the future. Meanwhile, bleach is still a big seller for the company, partly because Medicare stopped reimbursing hospitals for treating preventable hospital-acquired illnesses. "Bleach is the most mature category we compete in -- yet the category grew 14% over the last 3 months," said CEO Don Knauss.

Full Story:

Related Summaries